Discordance in Immunohistochemistry Results in Breast Pathologies: Effect of Chemotherapy, Specimen Characteristics, or Pathology Center?
Background: Immunohistochemical results are of vital importance in the classification of patients with breast cancer into subgroups and in treatment decision-making at every stage. However, differences can occur in biopsy results obtained from the same patient. In our study, we aimed to investigate...
Saved in:
| Main Author: | Mustafa Ersoy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Clinical Medicine Insights: Oncology |
| Online Access: | https://doi.org/10.1177/11795549251367498 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
by: Chikako Funasaka, et al.
Published: (2025-01-01) -
Digital Pathology for Analyzing Endomyocardial Biopsy Specimens
by: A. A. Slavinskiy, et al.
Published: (2023-08-01) -
Evaluation of Pathology Results of Patients with a History of Breast Cancer who were Operated on for Gynecological Pathologies or Prophylaxis
by: Necim Yalcin, et al.
Published: (2024-04-01) -
Concurrent Viewing of H&E and Multiplex Immunohistochemistry in Clinical Specimens
by: Larry E. Morrison, et al.
Published: (2025-01-01) -
Radiologic and Pathologic Discordance in Hepatocellular Carcinoma: More Than a Mismatch, with Prognostic Significance
by: Ijin Joo
Published: (2025-07-01)